ENDGAME STRATEGIES, LLC

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES · Trade association working to ensure generic and biosimilar medicines are more accessible.

Filing 3rd Quarter - Termination

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · Senate · $40,000.00 income · posted Sep 23, 2025

Lobbying activity 2

Issues relating to patent policy and drug pricing, and legislative proposals relating to Patent Trial & Appeal Board and patent eligibility.

Health Issues

Issues relating to patent policy and drug pricing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.